Literature DB >> 2021849

Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats.

D M Hemingway1, T G Cooke, S J Grime, D M Nott, S A Jenkins.   

Abstract

Experimental liver tumours were induced in the Hooded Lister rat by the intraportal inoculation of 10(6) HSN sarcoma cells. The hepatic perfusion index was raised 10 days after the inoculation of cells (at the micrometastatic stage) and when overt tumour was present 20 days after inoculation. Overt tumours were hypovascular compared with normal liver. Portal venous flow and portal venous inflow fell significantly when the hepatic perfusion index was increased, but hepatic arterial flow did not alter. Portal vascular resistance and splanchnic vascular resistance were both increased in tumour-bearing animals but portal pressure, arteriosystemic shunting and portosystemic shunting did not increase significantly at any stage during the growth of hepatic tumour. These findings confirm that the hepatic perfusion index can be elevated in the presence of both micrometastic and overt hepatic tumour and that the changes are not due to either arteriosystemic shunting or mechanical portal venous obstruction.

Entities:  

Mesh:

Year:  1991        PMID: 2021849     DOI: 10.1002/bjs.1800780319

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

Review 1.  Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer.

Authors:  Mario Kopljar; Leonardo Patrlj; Zeljko Bušić; Marijan Kolovrat; Mislav Rakić; Robert Kliček; Marcel Zidak; Igor Stipančić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

3.  Effects of Platelet-Derived Endothelial Cell Growth Factor and Doppler Perfusion Index in Patients with Colorectal Hepatic Metastases.

Authors:  Xueming Jiang; Zhixiang Zhang; Na Zhao; Xianghui He; Hao Guo
Journal:  Visc Med       Date:  2016-03-18

4.  Diagnostic value of measuring liver volume for detecting occult hepatic metastases from colorectal or gastric cancer.

Authors:  Takeaki Ishizawa; Tetsuhisa Yamamoto; Koichiro Nishida; Hajime Tsukui; Takayoshi Sekikawa
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Detection of hepatic metastases using duplex/color Doppler sonography.

Authors:  E Leen; J A Goldberg; J Robertson; G R Sutherland; D M Hemingway; T G Cooke; C S McArdle
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

6.  Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases. Evaluation with postoperative follow-up results.

Authors:  E Leen; W J Angerson; H Wotherspoon; B Moule; T G Cooke; C S McArdle
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

Review 7.  New MR techniques for the detection of liver metastases.

Authors:  J Ward
Journal:  Cancer Imaging       Date:  2006-05-31       Impact factor: 3.909

8.  Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer.

Authors:  D M Hemingway; T G Cooke; G McCurrach; R G Bessent; R Carter; J H McKillop; C S McArdle
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

9.  Effect of manipulation of primary tumour vascularity on metastasis in an adenocarcinoma model.

Authors:  M M Davies; P Mathur; P Carnochan; S Saini; T G Allen-Mersh
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distribution.

Authors:  J H Anderson; W J Angerson; N Willmott; D J Kerr; C S McArdle; T G Cooke
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.